Your browser doesn't support javascript.
loading
Clinical features and outcomes of COVID-19 and dengue co-infection: a systematic review.
Tsheten, Tsheten; Clements, Archie C A; Gray, Darren J; Adhikary, Ripon K; Wangdi, Kinley.
Afiliação
  • Tsheten T; Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia. tsheten.tsheten@anu.edu.au.
  • Clements ACA; Royal Centre for Disease Control, Ministry of Health, Thimphu, Bhutan. tsheten.tsheten@anu.edu.au.
  • Gray DJ; Telethon Kids Institute, Nedlands, Australia.
  • Adhikary RK; Curtin University, Perth, Australia.
  • Wangdi K; Research School of Population Health, College of Health and Medicine, Australian National University, Canberra, Australia.
BMC Infect Dis ; 21(1): 729, 2021 Aug 02.
Article em En | MEDLINE | ID: mdl-34340682
ABSTRACT

BACKGROUND:

Dengue is the most common arboviral disease in the tropical and sub-tropical regions of the world. Like other regions, dengue-endemic areas have faced the additional public health and socio-economic impact of the ongoing coronavirus disease 2019 (COVID-19) pandemic. COVID-19 and dengue co-infections have been reported, with complicated patient management and care requirements. This review aimed to collate and synthesise current knowledge on the clinical features and outcomes of COVID-19 and dengue virus co-infection, a potentially important new dimension to be considered in public health management of the COVID-19 pandemic.

METHODS:

A systematic literature review was conducted using PubMed, Web of Science and Scopus databases from 1st January to 21st November 2020. The key search terms used were "dengue" and "coronavirus". Descriptive analysis with graphical illustrations were used to present the clinical and laboratory parameters of the co-infection.

RESULTS:

Thirteen published papers and four news articles were included in the review. Most studies were case reports with a detailed description of the clinical and laboratory characteristics of the co-infection. All cases were in adults with the exception of a six-year old child. The common symptoms of co-infection were fever, dyspnea, headache, and cough. Common laboratory results included thrombocytopenia, lymphocytopenia, elevated transaminases, and leukopenia. Serious outcomes of co-infection included septic shock, acute respiratory disease syndrome and multi-organ failure, leading to death in some patients.

CONCLUSIONS:

COVID-19 and dengue co-infection was associated with severe disease and fatal outcomes. The correct diagnosis and treatment of co-infection poses a substantial challenge due to the overlapping clinical and laboratory parameters. Therefore, confirmative diagnostic tests are necessary for accurate and timely diagnosis and patient management.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue / Coinfecção / COVID-19 Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dengue / Coinfecção / COVID-19 Tipo de estudo: Diagnostic_studies / Systematic_reviews Limite: Adult / Child / Humans Idioma: En Revista: BMC Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália